Superoxide dismutase, catalase, glutathione peroxidase and NADPH oxidase in lead-induced hypertension

Kidney International

Volumn 63, Issue 1, 2003, Pages 186-194

  Vaziri, Nosratola D ^a,b   Lin, Ching Yi ^a   Farmand, Farbod ^a   Sindhu, Ram K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Catalase; Glutathione peroxidase; Hypertension; Lead; NAD(P)H oxidase; Nitric oxide; Oxidative stress; Superoxide; Superoxide dismutase; Tempol

Indexed keywords

CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; DRINKING WATER; GLUTATHIONE PEROXIDASE; LEAD ACETATE; MANGANESE SUPEROXIDE DISMUTASE; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME DEFICIENCY; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME SUBUNIT; HEART; HEART LEFT VENTRICLE; HYPERTENSION; IMMUNODETECTION; INCUBATION TIME; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SYSTOLIC BLOOD PRESSURE; TISSUE DISTRIBUTION; URINARY EXCRETION; WESTERN BLOTTING;

EID: 0037213435     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00711.x     Document Type: Article

References (34)

1. Vaziri ND, Ding Y, Ni Z, et al: Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: Effect of lazaroid therapy. Kidney Int 52:1042-1046, 1997
2. Gonick HC, Ding Y, Bondy SC, et al: Lead-induced hypertension: Interplay of nitric oxide and reactive oxygen species. Hypertension 30:1487-1492, 1997
3. Vaziri ND, Ding Y, Ni Z: Nitric oxide synthase expression in the course of lead induced hypertension. Hypertension 34:558-562, 1999
4. Vaziri ND, Liang K, Ding Y: Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int 56:1492-1498, 1999
5. Vaziri ND, Ding Y, Ni Z: Compensatory upregulation of NO synthase isoforms in lead-induced hypertension. Reversal by an SOD-mimetic drug. J Pharmacol Exp Ther 298:679-685, 2001
6. Sharp DS, Osterloh J, Becker CE, et al: Blood pressure and blood lead concentration in bus drivers. Environ Health Perspect 78:131-137, 1988
7. Harlan WR: The relationship of blood lead levels to blood pressure in the U.S. population. Environ Health Perspect 78:9-13, 1988
8. Khalil-Manesh F, Gonick HC, Weiler EW, et al: Effect of chelation treatment with dimercaptosuccinic acid (DMSA) on lead-related blood pressure changes. Environs Res 65:86-99, 1994
9. Ding Y, Gonick HC, Vaziri ND: Lead promotes hydroxyl radical generation and lipid peroxidation in cultured aortic endothelial cells. Am J Hypertens 13:552-555, 2000
10. Ding Y, Gonick HC, Vaziri ND, et al: Lead-induced hypertension: Increased hydroxyl radical production. Am J Hypertens 14:169-173, 2001
11. Ding Y, Vaziri ND, Gonick HC: Lead-induced hypertension. II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside. Environ Res 76:107-113, 1998
12. Vaziri ND, Ding Y: Effect of lead on NO synthase expression in coronary endothelial cells: Role of superoxide. Hypertension 37:223-226, 2001
13. Vaziri ND, Ni Z, Zhang YP, et al: Depressed renal and vascular nitric oxide synthase expression in cyclosporine-induced hypertension. Kidney Int 54:482-491, 1998
14. Vaziri ND, Ni Z, Oveisi F: Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 31:1248-1254, 1998
15. Vaziri ND, Oveisi F, Ding Y: Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int 53:1748-1754, 1998
16. Vaziri ND, Ni Z, Oveisi F, et al: Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 39:135-141, 2002
17. Navarro-Antolín J, Hernández-Perera O, López-Ongil S, et al: CsA and FK506 up-regulate eNOS expression: Role of reactive oxygen species and AP-1. Kidney Int 54(Suppl 68):S20-S24, 1998
18. Lopez-Ongil S, Hernandez-Perera O, Navarro-Antolin J, et al: Role of reactive oxygen species in the signaling cascade of cyclosporine A-mediated up-regulation of eNOS in vascular endothelial cells. Br J Pharmacol 124:447-454, 1998
19. Tschudi MR, Mesaros S, Luscher TF, et al: Direct in situ measurement of nitric oxide in mesenteric resistance arteries. Increased decomposition by superoxide in hypertension. Hypertension 27:32-35, 1996
20. Cosentino F, Patton S, D'Uscio LV, et al: Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest 101:1530-1537, 1998
21. Schnackenberg CG, Welch WJ, Wilcox CS: Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: Role of nitric oxide. Hypertension 32:59-64, 1998
22. Schnackenberg CG, Wilcox CS: Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin F2alpha. Hypertension 33:424-428, 1999
23. Vaziri ND, Ni Z, Oveisi F, Tarnavsky-Hobbs DL: Effect of antioxidant therapy on blood pressure and nitric oxide synthase expression in hypertensive rats. Hypertension 36:423-429, 2000
24. Atarashi K, Ishiyama A, Takagi M, et al: Vitamin E ameliorates the renal injury of Dahl salt-sensitive rats. Am J Hypertens 10:116S-119S, 1997
25. Swei A, Lacy F, Delano FA, et al: Oxidative stress in the Dahl hypertensive rat. Hypertension 30:1628-1633, 1997
26. Roberts CK, Vaziri ND, Wang XQ, et al: Enhanced NO inactivation and hypertension induced by a high fat, refined carbohydrate diet. Hypertension 36:423-429, 2000
27. Roberts CK, Vaziri ND, Liang K, et al: Reversibility of experimental syndromex by diet modification. Hypertension 37:1323-1328, 2001
28. Roggensack AM, Zhang Y, Davidge ST: Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension 33:83-89, 1999
29. Vaziri ND, Wang XQ, Oveisi F, et al: Induction of oxidative stress by glutathione depletion causes hypertension in normal rats. Hypertension 36:142-146, 2000
30. Samuni A, Krishna CM, Riesz P, et al: A novel metal-free low molecular weight superoxide dismutase mimic. J Biol Chem 263:17921-17924, 1988
31. Mitchell JB, Samuni A, Krishna MC, et al: Biologically active metal-independent superoxide dismutase mimetics. Biochemistry 29:2802-2807, 1990
32. Mates JM, Perez-Gomez C, Nunez de Castro IN: Antioxidant enzymes and human diseases. Clin Biochem 32:595-603, 1999
33. Rajagopalan S, Kurz S, Munzel T, et al: Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97:1916-1923, 1996
34. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW: Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141-1148, 1994